![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Decentralized Clinical Trials: From Words To Action
Discover how Cerba Research is participating to set good practices for decentralized…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – The Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 2.0, Real-Time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA
The aim of this study was to evaluate the ability of the…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Cell-Free DNA Analysis In Maternal Plasma In Cases Of Fetal Abnormalities Detected On Ultrasound Examination
Discover how we help to evaluate the utility of noninvasive prenatal testing…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Ultra-deep Sequencing Reveals High Prevalence And Broad Structural Diversity Of Hepatitis B Surface Antigen Mutations In A Global Population
Discover how we help this worldwide ultra-deep sequencing based genotyping study reveals…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Detection Of In Vivo Hepatitis B Virus Surface Antigen Mutations – A Comparison Of Four Routine Screening Assays
An important requirement for a state-of-the-art hepatitis B surface antigen (HBsAg) screening…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Clinical Performance Of Three Automated Screening Assays For Antibodies Against Nuclear Antigens
Using a defined serum panel of patients clinically diagnosed with various CTD…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – EliASymphony, The First Fully Automated Random Access Assay Using Only Recombinant Human Antigens And A Synthetic SmDpeptide To Screen For Autoantibodies Against Extractable Nuclear Antigens (ENA)
Using a defined serum panel of patients clinically diagnosed with CTD as…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Clinical Validation Of A Novel Automated Cell‐Free DNA Screening Assay For Trisomies 21, 13, And 18 In Maternal Plasma
Learn how Cerba Research helps to evaluate the clinical performance of a…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Prevalence Of SARS-CoV-2 Antibodies In France: Results From Nationwide Serological Surveillance
Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring…
Read more
![](https://cerbaresearch.com/app/uploads/2022/09/shutterstock_102818147-scaled.jpg)
Webinar – The Added Value Of Flow Cytometry In CAR T-Cell Clinical Trials Webinar
Watch Cerba Research’s latest webinar, ‘The Added Value of Flow Cytometry in…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
White Paper – Nonnegotiable Central Laboratory Capabilities For I/O Clinical Trial Success
In immuno-oncology (I/O), meeting budget and timeline expectations in the journey from…
Read more
![](https://cerbaresearch.com/app/uploads/2022/09/shutterstock_1658285683-scaled.jpg)
Webinar – In Light Of NASH: Liver Biopsy Optimization Webinar
Liver biopsies are the gold standard for Non-Alcoholic Steatohepatitis diagnosis and thus…
Read more
![Cerba US Expansion Tour VF.00_04_27_19.Still010](https://cerbaresearch.com/app/uploads/2022/07/Cerba-US-Expansion-Tour-VF.00_04_27_19.Still010.jpg)
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us